Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
SG

Simon Guile — 15 Patents

Astrazeneca Ab: 12 patents #60 of 1,971Top 4%
ALAstrazeneca Uk Limited: 3 patents #28 of 159Top 20%
Hathern, GB: #1 of 3 inventorsTop 35%
Overall (All Time): #307,048 of 4,157,543Top 8%
15 Patents All Time
Simon Guile has been granted 15 US patents while listed as an inventor at Astrazeneca Ab. The first was granted in 2001 and the most recent in January 2017. Simon Guile ranks #307,048 of 4,157,543 US inventors in our database (top 7.4%). Patent records list Simon Guile in Hathern, GB.

Patents per Year

Patents granted per year, 2001 to 2017Bar chart with a peak of 4 patents in 2008.peak 42001: 1 patents20012003: 1 patents20032004: 1 patents20042005: 2 patents20052006: 2 patents20062007: 1 patents20072008: 4 patents20082011: 1 patents20112012: 1 patents20122017: 1 patents2017

Issued Patents All Time

Showing 1–15 of 15 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
RE46276 Triazolo(4,5-D)pyrimidine compounds David Hardem, Anthony Ingall, Brian Springthorpe, Paul Willis 2017-01-17
8106073 Quinoline derivatives 057 Toby Thompson 2012-01-31 $8,905,000
7964616 Compounds 679 Mark Richard Ebden 2011-06-21 $4,946,000
7393854 Thienopyrimidinedinones and their use in modulation of autoimmune disease Anthony Ingall 2008-07-01 $20,646,000
7384950 Thienopyrimidinediones and their use in the modulation of autoimmune disease Rachel Heulwen Reynolds, Anthony Ingall, Rukhsana Rasul, Martin Cooper 2008-06-10 $5,253,000
7384951 Thienopyrimidinediones and their use in the modulation of autoimmune disease 2008-06-10 $5,253,000
7345047 Substituted [1,2,3]triazolo[4,5-d]pyrimidines Barrie Martin 2008-03-18 $6,668,000
7250419 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition David Hardern, Anthony Ingall, Brian Springthorpe, Paul Willis 2007-07-31 $36,849,000
7064126 Compounds Martin Cooper, Anthony Ingall, Rukhsana Rasul 2006-06-20 $10,429,000
7034032 Cyclopentan-2-ol-1-yl-[1,2,3]triazolo[4,5-D]pyrimidine compounds Roger Brown, Garry Pairaudeau, Brian Springthorpe 2006-04-25 $19,937,000
6974868 Compounds David Hardern, Anthony Ingall, Brian Springthorpe, Paul Willis 2005-12-13 $11,892,000
6844348 2,3,4-cyclopentan-2,3,4-triol-1-yl compounds Barrie Martin 2005-01-18 $9,400,000
6713483 [1,2,3]-triazolo[4,5-d] pyrimidine compounds Brian Springthorpe 2004-03-30 $35,813,000
6525060 Triazolo(4,5-d)pyrimidine compounds David Hardern, Anthony Ingall, Brian Springthorpe, Paul Willis 2003-02-25 $5,431,000
6251910 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists Anthony Ingall, Brian Springthorpe, Paul Willis 2001-06-26 $10,685,000